Manufacturing Operator

Updated: May 26, 2024 09:23 AM GMT

Johnson & Johnson

Sassenheim

Manufacturing Operators
(USP/DSP)

Would you like to be directly involved in supporting a new process that can change people’s life? Then keep reading!

The Lenti Viral Vector Facility:

Janssen Biologics B.V., part of Johnson & Johnson, is setting up a new production facility in Sassenheim. This new facility will produce lentiviral vector, which is used in the treatment for multiple myeloma, a disease affecting 160.000 patients globally.
The project team is preparing to get ready for commercial production in 2024. The coming years will be exciting, with construction and production milestones to be reached, and – equally important – a high performing team to be set up! Therefore, lots of interesting Operational challenges lay ahead, mainly in the area of Upstream, Downstream and Fill/Finish.
Are you energized to support a new organization within a global company? Do you want to contribute to improve the life of patients? Do you have a strong passion for people? Then this is your... More Detail